Population-Based Estimates of Survival and Cost for Metastatic Melanoma
Abstract
Fewer than half of all patients with metastatic melanoma survive more than 1 year. Standard treatments have had little success, but recent therapeutic advances offer the potential for an improved prognosis. In the present study, we used population-based administrative data to establish real-world baseline estimates of survival outcomes and costs against which new treatments can be compared.Data from administrative databases and patient...
Paper Details
Title
Population-Based Estimates of Survival and Cost for Metastatic Melanoma
Published Date
Oct 1, 2015
Journal
Volume
22
Issue
5
Pages
326 - 332
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History